RAC 1.27% $1.55 race oncology ltd

Cardiotoxicity publications have been increasing at an...

  1. 1,034 Posts.
    lightbulb Created with Sketch. 11589
    Cardiotoxicity publications have been increasing at an astounding pace since the 1970s. If there was a time to be bringing a cardioprotective agent with historic clinical efficacy to market, it is now. 2024 is on track to being another massive year for cardiotoxicity research - hopefully publications relating to Zantrene can be in that mix. For the record, publications on FTO is only 4000.

    https://hotcopper.com.au/data/attachments/6044/6044827-afa6b889e081d46df38c31f29a7815a7.jpg

 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.55
Change
-0.020(1.27%)
Mkt cap ! $264.0M
Open High Low Value Volume
$1.59 $1.62 $1.51 $218.3K 138.7K

Buyers (Bids)

No. Vol. Price($)
1 95 $1.53
 

Sellers (Offers)

Price($) Vol. No.
$1.55 157 1
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.